I am 71 years old and was diagnosed with pernicious anemia in October 2024. My B12 and folate levels were low. My antiparietal antibodies were abnormal, but the ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...

Advantages of EGS are high capacity, low carbon emissions, small land footprint, and flexibility to back up intermittent ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Jabil acquires Pharmaceutics International to enhance commercial prospects in the emerging market of CDMO services.

Flagstar Financial’s turnaround efforts drive a 15.2% surge. Read why FLG stock is a speculative buy with potential for ...

The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was ...

LONDON/SAN FRANCISCO (Reuters) - Novo Nordisk is under pressure from investors for more information about its next-generation ...

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...